Brides To Be Should Say ‘I Do’ To A Daily Multivitamin With Folic Acid
“For richer and for poorer, in sickness and in health,” are some of the most common words heard in wedding vows. But what is often overlooked is the health of the married couple’s future children. With National Folic Acid Awareness Month taking place January 12 through 18, 2009, brides-to-be should start thinking about saying “I do” to taking a daily multivitamin with 400 micrograms (mcg) of folic acid daily–to protect their own health and the health of their children-to-be.
Folate is a water-soluble B vitamin that occurs naturally in foods, such as leafy green vegetables, whereas folic acid is the synthetic form of folate that is found in supplements and added to fortified foods. This essential B-vitamin helps build and maintain healthy cells, which is especially critical for the developing fetus. Studies have shown that if taken before and during early pregnancy, folic acid can significantly reduce the number of birth defects of the brain and spine called neural tube defects (NTDs) by up to 70 percent.
Despite the food fortification program that began in 1998, which enriched breads, cereals, flours, corn meals, pastas, rice, and other grain products with folic acid, the average non-pregnant Caucasian woman gets only 128 mcg per day of folic acid from fortified food, according to a study published in the May 2007 issue of the American Journal of Clinical Nutrition–African American and Hispanic women get even less folic acid in their daily diet.
“There are nearly 60 million women in the U.S. who are of childbearing age,” says Elizabeth T. Jordan, DNSc, RNC, a perinatal clinical nurse specialist and member of the National Healthy Mothers, Healthy Babies Coalition Board of Directors. “We know that nearly half of all pregnancies in the U.S. are unplanned and that the average woman is getting less than one-third of the recommended amount of folic acid. We also know that the odds of having a baby born with an NTD could be greatly reduced by women of childbearing age getting the recommended amount of folic acid.” The easiest way to reduce the risk of having a baby born with an NTD is for women to begin taking a multivitamin with 400 mcg of folic acid today–not after they become pregnant, says Dr. Jordan.
According to the recent Healthcare Professionals (HCP) Impact Study, conducted by the “Life…supplemented” consumer wellness campaign, almost three quarters of physicians (72 percent) and more than three quarters of nurses (88 percent) say it is a good idea for patients to take a multivitamin–many of which contain 400 mcg of folic acid. According to the same survey, 86 percent of nurses and 87 percent of physicians personally take a multivitamin.
“Evidence suggests that the incidence of neural tube defects could be decreased as much as 70 percent if all women had an adequate folate intake during the periconceptual period,” says Dr. Jordan. “The neural tube begins to close within the first month of gestation, often before a woman realizes she is pregnant.”
To help remind brides-to-be of the importance of taking a daily multivitamin with folic acid, two organizations, the Council for Responsible Nutrition and the Healthy Mothers, Healthy Babies Coalition, have teamed up to develop a series of free e-postcards that can be sent to brides-to-be, reminding them to take care of their health. To wish a bride-to-be a lifetime of happiness and health, visit www.crnusa.org/commitment or http://www.hmhb.org.
The Council for Responsible Nutrition (CRN), founded in 1973, is a Washington, D.C.-based trade association representing dietary supplement industry ingredient suppliers and manufacturers. CRN members voluntarily adhere to a code of ethics and manufacture dietary supplements to high quality standards under good manufacturing practices.
The National Healthy Mothers, Healthy Babies Coalition (HMHB) is the only coalition of its kind which acts as a catalyst for change by creating partnerships among community groups, nonprofit organizations, professional associations, businesses and government agencies. The Coalition promotes optimal health for mothers and babies, and works to strengthen families and build healthy communities.
Council for Responsible Nutrition
http://www.crnusa.org
Scientists Isolate Genes That Made 1918 Flu Lethal
By mixing and matching a contemporary flu virus with the “Spanish flu” a virus that killed between 20 and 50 million people 90 years ago in history’s most devastating outbreak of infectious disease researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.
Writing in the Proceedings of the National Academy of Sciences, a team led by University of Wisconsin-Madison virologists Yoshihiro Kawaoka and Tokiko Watanabe identifies genes that gave the 1918 virus the capacity to reproduce in lung tissue, a hallmark of the pathogen that claimed more lives than all the battles of World War I combined.
“Conventional flu viruses replicate mainly in the upper respiratory tract: the mouth, nose and throat. The 1918 virus replicates in the upper respiratory tract, but also in the lungs,” causing primary pneumonia among its victims, says Kawaoka, an internationally recognized expert on influenza and a professor of pathobiological sciences in the UW-Madison School of Veterinary Medicine. “We wanted to know why the 1918 flu caused severe pneumonia.”
Autopsies of 1918 flu victims often revealed fluid-filled lungs severely damaged by massive hemorrhaging. Scientists assumed that the ability of the virus to take over the lungs is associated with the pathogen’s high level of virulence, but the genes that conferred that ability were unknown.
Discovery of the complex and its role in orchestrating infection in the lungs is important because it could provide a way to quickly identify the potential virulence factors in new pandemic strains of influenza, Kawaoka says. The complex could also become a target for a new class of antiviral drugs, which is urgently needed as vaccines are unlikely to be produced fast enough at the outset of a pandemic to blunt its spread.
To find the gene or genes that enabled the virus to invade the lungs, Kawaoka and his group blended genetic elements from the 1918 flu virus with those of a currently circulating avian influenza virus and tested the variants on ferrets, an animal that mimics human flu infection.
For the most part, substituting single genes from the 1918 virus onto the template of a much more benign contemporary virus yielded agents that could only replicate in the upper respiratory tract. One exception, however, included a complex of three genes that, acting in concert with another key gene, allowed the virus to efficiently colonize lung cells and make RNA polymerase, a protein necessary for the virus to reproduce.
“The RNA polymerase is used to make new copies of the virus,” Kawaoka explains. Without the protein, the virus is unable to make new virus particles and spread infection to nearby cells.
In the late 1990s, scientists were able to recover genes from the 1918 virus by looking in the preserved lung tissue of some of the pandemic’s victims. Using the relic genes, Kawaoka’s group was able to generate viruses that carry different combinations of the 1918 virus and modern seasonal influenza virus.
When tested, most of the hybrid viruses only infected the nasal passages of ferrets and didn’t cause pneumonia. But one did infect the lungs, and it carried the RNA polymerase genes from the 1918 virus that allowed the virus to make the key step of synthesizing its proteins.
In 2004, Kawaoka and his team identified another key gene from the 1918 virus that enhanced the pathogen’s virulence in mice. That gene makes hemagglutinin, a protein found on the surface of the virus and that confers on viral particles the ability to attach to host cells.
“Here, I think we are talking about another mechanism,” Kawaoka says. The RNA polymerase is used to make copies of the virus once it has entered a host cell. The role of hemagglutinin is to help the virus gain access to cells.
In addition to the study’s lead authors, Watanabe and Kawaoka, co-authors of the new PNAS paper are Shinji Watanabe, Jin Hyun Kim and Masato Hatta, also of UW-Madison; and Kyoko Shinya of Kobe University. The work was funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology and by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan.
University of Wisconsin-Madison
500 Lincoln Dr., 27 Bascom Hall
Madison
WI 53706
United States
http://www.wisc.edu
Published Reports Inaccurate Concerning Alcohol Consumption During Pregnancy
A national alcohol research group is concerned that the media’s misinterpretation of a recent British research study could encourage pregnant women to be more at ease with temperate alcohol consumption.
Some media reports erroneously stated that the study by The University College London researchers revealed that light drinking by pregnant women could be beneficial to their babies. Other articles said light drinking during pregnancy would not affect the behavior or mental acuity of babies born to drinking mothers.
The Fetal Alcohol Spectrum Disorders Study Group, a subgroup of the Research Society on Alcoholism, says the conclusion of the study was not reported accurately. “Unfortunately, several media outlets misinterpreted this report to mean that drinking improved the children’s outcome,” the FASD Study Group said.
The published report looked at the drinking patterns of pregnant mothers of three-year-olds and assessed the behavior and cognitive skills of the children. The University College London researchers actually reported that the children born to women who drank lightly during pregnancy were not at increased risk compared with children of mothers who did not drink during pregnancy.
However, this result may be based on the higher socioeconomic status of the light drinking mothers and their children involved in this study. Higher socioeconomic status is well known to improve an infant’s neurodevelopmental outcome. The study’s authors, Dr. Yvonne Kelly at University College London and colleagues, suggested this explanation for their findings and the FASD Study Group agrees with that conclusion.
Many published reporters show that even moderate to light drinking can cause birth defects.
“Generally, the adverse effects of light drinking during pregnancy are subtle and may go undetected in children,” said Feng Zhou, Ph.D., president of the FASD Study Group and a professor of anatomy, cell biology and neurobiology at the Indiana University School of Medicine. “Other alcohol research studies of moderate drinking during pregnancy have shown an adverse impact on multiple aspects of development through adolescence and young adulthood even when other important environmental factors are taken into account.”
Dr. Zhou said the news reporters have been carried in various European and American publications and on news web sites.
“The media reports are alarming for a number of reasons but it is particularly disturbing at this time of year when holiday parties may make alcohol consumption more accessible and appealing to pregnant women who have read the erroneous reports,” he said.
The consensus of public health providers and alcohol researchers is that even light drinking can interfere with biological processes critical in the development of the fetal brain, said Dr. Zhou and other Study Group officers, Cynthia J.M. Kane, Ph.D., vice president and professor of neurobiology and developmental sciences, University of Arkansas for Medical Sciences, and Susan Smith, Ph.D., secretary and treasurer, and professor of nutritional science at the University of Wisconsin- Madison.
For additional information compiled by the Study Group on the research into the effects on the children of mothers who consume alcohol during pregnancy, see http://www.rsoa.org/fas.html.
FASD Study Group
South Asian Children From Relatively Well Off Families More Likely To Die In Intensive Care
Children of South Asian ethnicity from the least deprived backgrounds are more likely to die in intensive care than other children, reveals research published ahead of print in the Archives of Disease in Childhood.
The findings are based on admissions to 29 paediatric intensive care units across England and Wales between 2004 and 2007 for children under the age of 16.
The researchers calculated admission rates according to levels of deprivation and ethnic background. They then calculated the subsequent risk of death.
During the study period, 40,303 children were admitted to paediatric intensive care units in England and Wales, giving a rate of 98 per 100,000 of the child population or 0.1%.
Just under 11% were classified as coming from a South Asian background, and half of all children admitted were under 12 months of age.
The figures showed that children of South Asian ethnicity were 36% more likely to be admitted to intensive care than children of other ethnicities, based on rates per 100,000 of the child population.
Children with a South Asian background were 36% more likely to die while receiving intensive care than children of other ethnic backgrounds.
And children with this ethnic background, who lived in areas of least deprivation, were more than twice as likely to die in intensive care as those living in areas of the greatest deprivation.
But there is no obvious explanation for the findings, say the authors.
“Although there is some evidence that class inequalities in self related health seen in the white population are not apparent in Pakistani and Bangladeshi adults, it is not clear why there is such a strong interaction between less deprived children of South Asian origin and excess mortality,” they write.
National data show that overall infant mortality for England and Wales stands at 5.2 deaths for every 1000 births. But the rate is higher among communities of South Asian ethnicity.
Among babies born to mothers of Pakistani origin, for example, the rate is double the national average, at 10.5 deaths for every 1000 births.
“Epidemiology of critically ill children in England and Wales: incidence, mortality, deprivation, ethnicity”
Online First Arch Dis Child 2008; doi 10.1136/adc.2007.134403
Click here to view abstract online.
Archives of Disease in Childhood
Bovine TB Infection Still Threatens Human Health In The UK
Bovine tuberculosis (TB) still remains a threat to human health in the UK, although the overall risk of infection is considered to be small, reveals research published in the journal Thorax.
The researchers detail three cases of TB infection arising in rural Cornwall, South West England.
Two confirmed cases of bovine TB caused by Mycobacterium bovis arose in a woman and her pet dog. A third case of latent infection occurred in the woman’s 12 year old daughter, who had not been vaccinated against TB.
Before diagnosis, the 42 year old woman had felt generally unwell for a month and had had a chesty cough .
She had not drunk unpasteurised milk, recently travelled abroad, or had a compromised immune system-all factors associated with an increased risk of M bovis TB infection in the UK.
But she had worked as a veterinary nurse in the South West of England, and the strain of M bovis she had is a common cause of TB in cattle and badgers in this area.
Her pet dog developed a persistent cough four months later, and was diagnosed with TB. Further analysis revealed that it had been infected with the same strain of M bovis as its owner .
As part of routine procedures, household members were also tested for TB. Only the woman’s 12 year old daughter tested positive although she did not have any symptoms.
Like her mother, she had not drunk unpasteurised milk, travelled abroad, or had a compromised immune system.
This particular form of TB infection remains “a serious animal health problem in the UK, despite longstanding statutory surveillance and control measures,” say the authors.
But they emphasise that their case reports should not cause undue alarm. Despite the rise in the number of cases of TB infection identified in cattle since the mid 1980s, bovine TB infections account for less than 1% of laboratory confirmed cases of TB in people.
These figures are similar to those in other industrialised countries.
TB infection in animals can be passed on to people through breathing in airborne infectious droplets, drinking unpasteurised milk, or, more rarely, contact with broken skin.
The authors point out that these cases indicate that bovine TB is not a disease of the past, as has been suggested, and that it poses a “low, but ongoing, public health risk.”
Doctors, vets, and public health officials need to remain vigilant for signs of this “often forgotten infection,” they warn.
“Human and canine pulmonary Mycobacterium bovis infection in the same household: re-emergence of an old zoonotic threat?”
Thorax 2009; 64: 89-91
Click here to view abstract online.
Thorax
Weight Bearing Exercise In Adolescence Best For Strong Bones In Older Age
Weight bearing exercise during adolescence seems to be the best for maintaining bone strength in older life, indicates a small study published ahead of print in the British Journal of Sports Medicine.
The research team assessed the impact of exercise between the ages of 12 and 18 on preserving bone strength in later life among 46 women.
The women were all aged from 52 to 73, and had already gone through the menopause.
They were grouped according to what type of sporting activities they had done during their physically formative adolescent years.
Eighteen had participated in sports involving high impact (running and jumping) activities, such as tennis, athletics, and volleyball, while 30 had either participated in low impact (swimming) weight bearing exercise or none at all.
Indicators of bone structure (mineral density and content) were assessed in the spine and thigh bone (femur), and the size and geometry of the femur were also measured.
The size, shape, and structure of the bones all reflect bone strength and how well the skeleton compensates for the bone loss that naturally occurs after the menopause.
There was no difference in bone mineral density between the two groups, but those who had participated in weight bearing sports between the ages of 12 and 18 had significantly greater bone mineral content in both the spine and the thigh bone than those who had not.
Their outer femoral bone area was also larger, affording greater resistance to fracture during pressure from movements, such as bending.
None of those with the strongest bones were doing any weight bearing exercise at the time of the study, suggesting that the benefits of this type of exercise during adolescence last for over 40 years, say the authors.
“Adolescent exercise associated with long term superior measures of bone geometry: a cross sectional DXA and MRI study”
Online First Br J Sports Med 2008; doi 10.1136/bjsm.2008.052308
Click here to view article online.
British Journal of Sports Medicine
How To Fight Malaria By Changing The Environment – MIT Computer Modeling Finds Leveling Land Can Help Control Disease’s Spread
Modifying the environment by using everything from shovels and plows to plant-derived pesticides may be as important as mosquito nets and vaccinations in the fight against malaria, according to a computerized analysis by MIT researchers.
The researchers have developed a new computer model for analyzing different methods of trying to control the spread of malaria, one of the world’s most-devastating diseases. Among their findings using the model is that environmental measures such as leveling the land to eliminate depressions where pools can form can be an important part of the strategy for controlling the disease.
Reports on the work, carried out by Professor of Civil and Environmental Engineering Elfatih Eltahir and graduate students Arne Bomblies and Rebecca Gianotti, were presented this week at a meeting of the American Geophysical Union in San Francisco.
Malaria, Eltahir explained, is “a significant global health challenge” that accounts for one-third of all deaths of children under 5 worldwide. By developing new software to analyze the impacts of different methods of attempting to limit malaria’s spread, which involves a complex chain of transmission between larvae, mosquitoes and humans, “we have made significant progress” toward better control of the disease, he said.
v
While most efforts at dealing with malaria have focused on the human side, such as attempts to develop a vaccine, Eltahir said that efforts to control environmental factors -such as working to eliminate the low spots where pools of water collect during the rainy season, or applying locally grown plant materials to limit the growth of mosquitoes – can have a dramatic effect on controlling malaria’s spread. And unlike importing expensive medicines, such an approach can rely on local efforts as simple as having people with shovels fill in the low spots in the terrain.
“By using local tools and local labor, our approach relies less on high-technology equipment from outside the region, which tends to make the local people more dependent,” he said.
In addition, the new comprehensive computer model will provide a tool for analyzing how different areas’ vulnerability to malaria will be affected by a changing climate.
To validate the accuracy of the computer modeling of conditions, the team has been working for the last four years in a remote area of Niger, which lies in the Sahel desert region of northern Africa. “Africa is the hot spot for malaria in general,” Eltahir explained, so this fieldwork provides substantial validation of the model.
In the field, Bomblies and others have monitored every aspect of malaria’s lifecycle, including doing counts of mosquito larvae and adult mosquitoes, identifying the exact species of mosquitoes (since only specific varieties carry the malaria parasite), and mapping the topography and monitoring the size and duration of pools of water where the mosquitoes breed. “We gathered data that would serve as validation for the model that we were developing,” Bomblies said.
Eliminating pools of standing water, or increasing drainage so that such pools last less than the seven to 10 days it takes for the mosquitoes to mature, can be an effective strategy, the analysis shows. In addition, it allows comparison of different methods. Filling in the low spots using shovels, it turns out, is as effective at controlling the disease as plowing the land so that water more rapidly percolates down into the soil.
That is not a new idea, but the new software provides a quantitative way to compare its impact with other approaches, and to develop specific strategies for a given region. Filling in low spots “is an established technique,” said Bomblies, who has spent a total of 13 months leading the fieldwork in Niger. “But it hasn’t been specifically applied in the region in which we’ve been working.”
And unlike other approaches such as vaccinations or mosquito nets, it has a relatively permanent impact. “Once a breeding site is gone, it’s gone” Bomblies said.
Other methods the team has studied include spreading ground up seeds from the neem tree, which grows locally, in the ponds, which can reduce the mosquito population by about 50 percent.
“For the first time, we have a detailed computer model” of all the different factors in the disease’s spread, Eltahir said. By making it possible to run detailed simulations of a wide variety of strategies, “we can do a lot of things, in this region or elsewhere, that we could never do in the past. It can allow you to do things in a more cost-effective way.”
This project has been funded by the ocean and human health program of the National Oceanographic and Atmospheric Administration (NOAA), and the National Science Foundation.
Written by David Chandler, MIT News Office
MIT
New Survey Tool Assesses Provider Satisfaction With Population Health Management
A new survey tool from DMAA: The Care Continuum Alliance allows health plans, disease management companies and other stakeholders to better understand providers’ experiences with and attitudes toward population health improvement programs.
DMAA developed the “Provider Satisfaction Survey” because the success of disease management, wellness and other population-based interventions can depend on the satisfaction of providers, who play an important role by referring patients and managing and coordinating patient care. In a recent DMAA market survey, health plans, employers and population health improvement organizations all ranked physician engagement among the three strongest determinants of program success.
“The better we understand provider attitudes toward population health management, the better able we are to make program changes that enhance that relationship and improve patient care,” DMAA President and CEO Tracey Moorhead said. “Health care purchasers value patient and provider satisfaction. Our survey provides a simple, validated tool to measure that.”
Development of the survey came in two phases, with the first convening diverse provider focus groups to identify the survey’s scope and areas of assessment. DMAA translated that feedback into a first draft of the questionnaire, which it pre-tested with providers, who completed the survey and discussed their experiences in one-on-one interviews. The survey examines provider satisfaction with patient reports; program impact on practice and patient relationships; and impact on patient health and the provider’s ability to manage patient health.
v
In 2006, DMAA and J.D. Power and Associates produced a validated participant satisfaction survey, which has been adopted by major health care purchasers and payers nationwide.
About DMAA: The Care Continuum Alliance
DMAA: The Care Continuum Alliance convenes all stakeholders providing services along the care continuum toward the goal of population health improvement. These care continuum services include strategies such as health and wellness promotion, disease management, and care coordination. DMAA: The Care Continuum Alliance promotes the role of population health improvement in raising the quality of care, improving health outcomes and reducing preventable health care costs for individuals with chronic conditions and those at risk for developing chronic conditions. DMAA’s activities in support of these efforts include advocacy, research and the promotion of best practices in care management.
DMAA: The Care Continuum Alliance represents more than 200 corporate and individual stakeholders – including wellness, disease and care management organizations, pharmaceutical manufacturers and benefit managers, health information technology innovators, biotechnology innovators, employers, physicians, nurses and other health care professionals, and researchers and academicians. Visit DMAA on the Web at http://www.dmaa.org.
DMAA: The Care Continuum Alliance
Publication Of Research On Use Of Umbilical Cord Blood In Growing Undifferentiated Embryonic Stem Cells
Proteonomix, Inc.
(PINKSHEETS: PROT) announces the publication in Cloning and Stem
Cells Journal Volume 10 No. 4, published on November 20, 2008 by Mary
Ann Liebert, Inc., of an article entitled “Cells Derived from Human
Umbilical Cord Blood Support the Long-Term Growth of Undifferentiated
Human Embryonic Stem Cells.”
The publication, authored by Xiangcan Zhan, Ph.D. et al. of The
Kennedy Krieger Institute and The Johns Hopkins University, describes
the utilization of umbilical cord blood components to act as feeder
cells (part of a cell growth medium) for the growth of
undifferentiated embryonic stem cells. This breakthrough may provide,
for the first time, the ability to grow embryonic stem cells without
differentiation on material that is currently being used in human
transplants. The technology described in the study was co-invented
with the Johns Hopkins University. An undifferentiated cell has the
capacity to remain a stem cell until directed to become another type
of cell such as a cardiac cell, beta (insulin producing) cell, nerve
cell and others.
Human embryonic stem cells are currently cultured with animal feeder
cells which can transmit pathogens to the human cells, limiting their
ability to be transplanted for medical purposes. Michael Cohen,
President of Proteonomix, Inc., is the co-inventor of key components
of the technology upon which this publication is based. Proteonomix
has begun to commercialize this technology — initially to academic
and corporate research laboratories which are incorporating stem cell
therapies in the cure of multiple diseases including, but not limited
to, diabetes, cardiac, and neurological diseases.
Michael Cohen commented, “We hope to create a therapeutic laboratory
standard by commercializing this technology and licensing it to
pharmaceutical companies and hospitals which are developing human
embryonic cell therapeutics. We estimate that over 40,000 laboratories
in pharmaceutical companies and hospitals could employ this
technology.”
About Proteonomix, Inc.
Proteonomix, Inc. is a biotechnology company focused on developing
therapeutics based upon the use of human cells and their derivatives.
It is developing an intellectual property portfolio in the areas of
therapeutics and cosmetics. Its research and development program has
demonstrated results with more than ten patent applications and
multiple products ready to enter their respective markets.
Proteonomix has facilities at a number of academic institutions. Its
subsidiary, Proteoderm, has developed a line of anti-aging cosmetics.
For more information, please visit http://www.proteonomix.com or
http://www.proteoderm.com and http://www.pinksheets.com.
“Safe Harbor Statement”
Under the Private Securities Litigation Reform Act of 1995,
statements herein relating to the Company’s expectations are
forward-looking statements. The anticipated results, including the
entering into an agreement reflecting the terms of the letter of
intend and performance pursuance thereto may not occur.
Proteonomix, Inc.
PharmaCom BioVet, Inc. Begins Nationwide Rollout Of Advanced Veterinary Oncology Centers
PharmaCom BioVet, Inc.
(PINKSHEETS: PHMB) is pleased to announce the company is now
beginning the process of locating commercial sites throughout the
continental United States to begin the full scale build out of the
nation’s first branded dedicated Veterinary Oncology Centers.
These centers are going to provide cancer treatment to companion
animals using licensed proprietary technologies. PharmaCom BioVet,
Inc. expects to garner a significant market share of the overwhelming
41 billion dollar per year veterinary market as the result of early
efforts put in by management in seeking out superior treatments and
devices.
According to Sharon Berthold, Executive Vice President of PharmaCom
BioVet, Inc., “Recent collaborations with world renowned veterinary
oncology specialists have allowed us the opportunity to create what I
believe are the foremost in companion animal oncology treatments.
Recent financial commitments from Investment bankers have allowed us
the opportunity to build out our centers on a national scale. We will
be concentrating heavily on the branding of PharmaCom BioVet, Inc.
using a marketing plan which includes commercials and literature to
be distributed to veterinary partners.”
About Us
PharmaCom BioVet, Inc. (PHMB) is quickly positioning itself to become
the leader in specialized veterinary oncology (cancer treatment
facilities for animals). PHMB management is planning the rollout of
specialized veterinary oncology treatment centers that will be
strategically located throughout the United States. PHMB has licensed
a series of proprietary devices and compounds that will enable
animals suffering from cancer greater life expectancy and decreased
suffering. http://www.pharmacombiovet.com
Disclosure
“Safe Harbor” statement under the Private Securities Litigation
Reform Act of 1995: This press release contains forward-looking
statements that are subject to risk and uncertainties, including, but
not limited to, the impact of competitive products, product demand,
market acceptance risks, fluctuations in operating results, political
risk and other risks detailed from time to time in PharmaCom BioVet,
Inc.’s filings with the Securities and Exchange Commission. These
risks could cause PharmaCom BioVet, Inc.’s actual results to differ
materially from those expressed in any forward-looking statements
made by, or on behalf of, PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc.
